Trial Profile
A phase I/II trial of CORT 108297 for antipsychotic-induced weight gain.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 28 Mar 2011
Price :
$35
*
At a glance
- Drugs CORT 108297 (Primary)
- Indications Obesity; Weight gain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Corcept Therapeutics
- 26 Feb 2010 New trial record